
Genespire Announces Oral Presentation At The ASGCT Annual Meeting Detailing Preclinical Insights Into Dosing For First-...
(MENAFN- GlobeNewsWire - Nasdaq) Milan, ITALY – 8 May 2025 – Genespire, a biotechnology company developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases, today announces an upcoming oral presentation showcasing critical …